Analysis of JAK2V617F mutation in Chinese patients with myeloproliferative disorders

American Journal of Hematology

Volumn 82, Issue 6, 2007, Pages 458-459

  Chen, Suning ^a   Fei, Hairong ^a   Zhang, Ri ^a   Xue, Yongquan ^a   Pan, Jinlan ^a   Wu, Yafang ^a   Ceng, Jiannong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

JAK2; Mutation; Myeloproliferative disorders; PCR

Indexed keywords

ACETIC ACID; JANUS KINASE 2; METHANOL; PHENYLALANINE; VALINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHROMOSOME ANALYSIS; DNA EXTRACTION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POINT MUTATION; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTHEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CHILD; CHINA; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 34249778385     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20872     Document Type: Article

References (7)

1. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythaemia vera. Nature 2005;434:1144-1148.
2. Levine RL, Wadleigh M, Cools J, et al. Activating mutation of the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005;7:387-397.
3. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative diseases. Lancet 2005;365:1054-1061.
4. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352:1779-1790.
5. Zhao R, Xing S, Li Z, et al. Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem 2005;280:22788-22792.
6. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006;107:4214-4222.
7. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-2302.